Literature DB >> 11060297

Polyhydroxybenzoates inhibit ascorbic acid activation of mitochondrial glycerol-3-phosphate dehydrogenase: implications for glucose metabolism and insulin secretion.

W W Wells1, D P Xu, M P Washburn, H K Cirrito, L K Olson.   

Abstract

Glycerol-3-phosphate dehydrogenase from pig brain mitochondria was stimulated 2.2-fold by the addition of 50 microm l-ascorbic acid. Enzyme activity, dependent upon the presence of l-ascorbic acid, was inhibited by lauryl gallate, propyl gallate, protocatechuic acid ethyl ester, and salicylhydroxamic acid. Homogeneous pig brain mitochondrial glycerol-3-phosphate dehydrogenase was activated by either 150 microm L-ascorbic acid (56%) or 300 microm iron (Fe(2+) or Fe(3+) (62%)) and 2.6-fold by the addition of both L-ascorbic acid and iron. The addition of L-ascorbic acid and iron resulted in a significant increase of k(cat) from 21.1 to 64.1 s(-1), without significantly increasing the K(m) of L-glycerol-3-phosphate (10.0-14.5 mm). The activation of pure glycerol-3-phosphate dehydrogenase by either L-ascorbic acid or iron or its combination could be totally inhibited by 200 microm propyl gallate. The metabolism of [5-(3)H]glucose and the glucose-stimulated insulin secretion from rat insulinoma cells, INS-1, were effectively inhibited by 500 microm or 1 mm propyl gallate and to a lesser extent by 5 mm aminooxyacetate, a potent malate-aspartate shuttle inhibitor. The combined data support the conclusion that l-ascorbic acid is a physiological activator of mitochondrial glycerol-3-phosphate dehydrogenase, that the enzyme is potently inhibited by agents that specifically inhibit certain classes of di-iron metalloenzymes, and that the enzyme is chiefly responsible for the proximal signal events in INS-1 cell glucose-stimulated insulin release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060297     DOI: 10.1074/jbc.M007268200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Haploinsufficiency of the GPD2 gene in a patient with nonsyndromic mental retardation.

Authors:  Hussein Daoud; Nicolas Gruchy; Jean-Marc Constans; Edgar Moussaoui; Simone Saumureau; Nadia Bayou; Maïté Amy; Sylviane Védrine; Phi Yen Vu; Agnès Rötig; Frédéric Laumonnier; Patrick Vourc'h; Christian R Andres; Nathalie Leporrier; Sylvain Briault
Journal:  Hum Genet       Date:  2008-11-16       Impact factor: 4.132

2.  Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice.

Authors:  Takafumi Senmaru; Masahiro Yamazaki; Hiroshi Okada; Mai Asano; Michiaki Fukui; Naoto Nakamura; Hiroshi Obayashi; Yoshitaka Kondo; Naoki Maruyama; Akihito Ishigami; Goji Hasegawa
Journal:  J Clin Biochem Nutr       Date:  2011-11-01       Impact factor: 3.114

3.  Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Authors:  Christopher D Green; Donald B Jump; L Karl Olson
Journal:  Endocrinology       Date:  2009-02-19       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.